Normative Cognitive Decline in Old Age
Objective To characterize trajectories of normative cognitive aging. Methods Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 po...
Gespeichert in:
Veröffentlicht in: | Annals of neurology 2020-06, Vol.87 (6), p.816-829 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 829 |
---|---|
container_issue | 6 |
container_start_page | 816 |
container_title | Annals of neurology |
container_volume | 87 |
creator | Wilson, Robert S. Wang, Tianhao Yu, Lei Bennett, David A. Boyle, Patricia A. |
description | Objective
To characterize trajectories of normative cognitive aging.
Methods
Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 postmortem markers of common neurodegenerative and cerebrovascular conditions. To accommodate the heterogeneity in cognitive trajectories, we used functional mixed effects models, which allow individuals to have different patterns of cognitive decline under a unified model structure.
Results
In a functional mixed effects model, postmortem markers (Alzheimer disease pathology, Lewy bodies, transactive response DNA‐binding protein 43 pathology, hippocampal sclerosis, atherosclerosis, gross infarcts) were associated with global cognitive decline. Residual global cognitive decline after adjustment for neuropathologic burden was weakly related to age at death; it occurred in only about one‐third of participants, mostly proximate to death. Results were comparable after eliminating the initial cognitive assessments to minimize retest learning or controlling for frailty proximate to death. Analyses were also conducted with composite measures of episodic memory and perceptual speed. Residual decline not attributable to neuropathologic burden was confined to a subset for each outcome and was most evident proximate to death. Age at death was unrelated to residual decline in episodic memory but was related to residual decline in perceptual speed.
Interpretation
Late life cognitive loss mainly reflects non‐normative pathologic and mortality‐related processes rather than normative age‐related processes. ANN NEUROL 2020;87:816–829 |
doi_str_mv | 10.1002/ana.25711 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10035056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2405201633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5101-f1f264547f56441e506f0dcb45f8bc999ce17794c43e2573c095d5c16b54cc43</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk4v_ANSEEQvuuXkq8uVlPkJY7vZfWjTdGa06Wy3yf69cZ1DBa8SkofnvOdF6BJwHzAmg8QlfcIjgCPUBU4hHBImj1EXU8FCDpR10FnTLDDGUgA-RR1KgLFI0i66mVR1mazsxgSjau7s7vZgdGGdCawLpkUWxHNzjk7ypGjMxf7sodnT42z0Eo6nz6-jeBxqDhjCHHIiGGdRzgVjYDgWOc50yng-TLWUUhuIIsk0o8YHphpLnnENIuVM-8ceum-1y3Vamkwbt6qTQi1rWyb1VlWJVb9_nH1T82qjfA2UYy684XZvqKv3tWlWqrSNNkWROFOtG0VoxCj3GcCj13_QRbWunV9PEYY5wSAo9dRdS-m6apra5Ic0gL_GEuXbV7v2PXv1M_6B_K7bA4MW-LCF2f5vUvEkbpWfW4GLfg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405201633</pqid></control><display><type>article</type><title>Normative Cognitive Decline in Old Age</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Wilson, Robert S. ; Wang, Tianhao ; Yu, Lei ; Bennett, David A. ; Boyle, Patricia A.</creator><creatorcontrib>Wilson, Robert S. ; Wang, Tianhao ; Yu, Lei ; Bennett, David A. ; Boyle, Patricia A.</creatorcontrib><description>Objective
To characterize trajectories of normative cognitive aging.
Methods
Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 postmortem markers of common neurodegenerative and cerebrovascular conditions. To accommodate the heterogeneity in cognitive trajectories, we used functional mixed effects models, which allow individuals to have different patterns of cognitive decline under a unified model structure.
Results
In a functional mixed effects model, postmortem markers (Alzheimer disease pathology, Lewy bodies, transactive response DNA‐binding protein 43 pathology, hippocampal sclerosis, atherosclerosis, gross infarcts) were associated with global cognitive decline. Residual global cognitive decline after adjustment for neuropathologic burden was weakly related to age at death; it occurred in only about one‐third of participants, mostly proximate to death. Results were comparable after eliminating the initial cognitive assessments to minimize retest learning or controlling for frailty proximate to death. Analyses were also conducted with composite measures of episodic memory and perceptual speed. Residual decline not attributable to neuropathologic burden was confined to a subset for each outcome and was most evident proximate to death. Age at death was unrelated to residual decline in episodic memory but was related to residual decline in perceptual speed.
Interpretation
Late life cognitive loss mainly reflects non‐normative pathologic and mortality‐related processes rather than normative age‐related processes. ANN NEUROL 2020;87:816–829</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.25711</identifier><identifier>PMID: 32144793</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Age ; Aged ; Aged, 80 and over ; Aging ; Aging - psychology ; Alzheimer's disease ; Arteriosclerosis ; Atherosclerosis ; Autopsy ; Biomarkers ; Cerebrovascular Disorders - pathology ; Cerebrovascular Disorders - psychology ; Cognitive ability ; Cognitive Dysfunction - psychology ; Death ; Dementia disorders ; Deoxyribonucleic acid ; DNA ; Educational Status ; Female ; Frailty - psychology ; Heterogeneity ; Hippocampus ; Humans ; Lewy bodies ; Longitudinal Studies ; Male ; Markers ; Memory ; Memory, Episodic ; Mortality ; Neurodegenerative diseases ; Neurodegenerative Diseases - pathology ; Neurodegenerative Diseases - psychology ; Neurologic Examination ; Neuropathology ; Neuropsychological Tests ; Older people ; Pathology ; Reaction Time ; Reference Values</subject><ispartof>Annals of neurology, 2020-06, Vol.87 (6), p.816-829</ispartof><rights>2020 American Neurological Association</rights><rights>2020 American Neurological Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5101-f1f264547f56441e506f0dcb45f8bc999ce17794c43e2573c095d5c16b54cc43</citedby><cites>FETCH-LOGICAL-c5101-f1f264547f56441e506f0dcb45f8bc999ce17794c43e2573c095d5c16b54cc43</cites><orcidid>0000-0001-9592-0333 ; 0000-0002-0237-8758</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.25711$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.25711$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32144793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, Robert S.</creatorcontrib><creatorcontrib>Wang, Tianhao</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Bennett, David A.</creatorcontrib><creatorcontrib>Boyle, Patricia A.</creatorcontrib><title>Normative Cognitive Decline in Old Age</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Objective
To characterize trajectories of normative cognitive aging.
Methods
Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 postmortem markers of common neurodegenerative and cerebrovascular conditions. To accommodate the heterogeneity in cognitive trajectories, we used functional mixed effects models, which allow individuals to have different patterns of cognitive decline under a unified model structure.
Results
In a functional mixed effects model, postmortem markers (Alzheimer disease pathology, Lewy bodies, transactive response DNA‐binding protein 43 pathology, hippocampal sclerosis, atherosclerosis, gross infarcts) were associated with global cognitive decline. Residual global cognitive decline after adjustment for neuropathologic burden was weakly related to age at death; it occurred in only about one‐third of participants, mostly proximate to death. Results were comparable after eliminating the initial cognitive assessments to minimize retest learning or controlling for frailty proximate to death. Analyses were also conducted with composite measures of episodic memory and perceptual speed. Residual decline not attributable to neuropathologic burden was confined to a subset for each outcome and was most evident proximate to death. Age at death was unrelated to residual decline in episodic memory but was related to residual decline in perceptual speed.
Interpretation
Late life cognitive loss mainly reflects non‐normative pathologic and mortality‐related processes rather than normative age‐related processes. ANN NEUROL 2020;87:816–829</description><subject>Age</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Aging - psychology</subject><subject>Alzheimer's disease</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Autopsy</subject><subject>Biomarkers</subject><subject>Cerebrovascular Disorders - pathology</subject><subject>Cerebrovascular Disorders - psychology</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - psychology</subject><subject>Death</subject><subject>Dementia disorders</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Educational Status</subject><subject>Female</subject><subject>Frailty - psychology</subject><subject>Heterogeneity</subject><subject>Hippocampus</subject><subject>Humans</subject><subject>Lewy bodies</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Markers</subject><subject>Memory</subject><subject>Memory, Episodic</subject><subject>Mortality</subject><subject>Neurodegenerative diseases</subject><subject>Neurodegenerative Diseases - pathology</subject><subject>Neurodegenerative Diseases - psychology</subject><subject>Neurologic Examination</subject><subject>Neuropathology</subject><subject>Neuropsychological Tests</subject><subject>Older people</subject><subject>Pathology</subject><subject>Reaction Time</subject><subject>Reference Values</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF1LwzAUhoMobk4v_ANSEEQvuuXkq8uVlPkJY7vZfWjTdGa06Wy3yf69cZ1DBa8SkofnvOdF6BJwHzAmg8QlfcIjgCPUBU4hHBImj1EXU8FCDpR10FnTLDDGUgA-RR1KgLFI0i66mVR1mazsxgSjau7s7vZgdGGdCawLpkUWxHNzjk7ypGjMxf7sodnT42z0Eo6nz6-jeBxqDhjCHHIiGGdRzgVjYDgWOc50yng-TLWUUhuIIsk0o8YHphpLnnENIuVM-8ceum-1y3Vamkwbt6qTQi1rWyb1VlWJVb9_nH1T82qjfA2UYy684XZvqKv3tWlWqrSNNkWROFOtG0VoxCj3GcCj13_QRbWunV9PEYY5wSAo9dRdS-m6apra5Ic0gL_GEuXbV7v2PXv1M_6B_K7bA4MW-LCF2f5vUvEkbpWfW4GLfg</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Wilson, Robert S.</creator><creator>Wang, Tianhao</creator><creator>Yu, Lei</creator><creator>Bennett, David A.</creator><creator>Boyle, Patricia A.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9592-0333</orcidid><orcidid>https://orcid.org/0000-0002-0237-8758</orcidid></search><sort><creationdate>202006</creationdate><title>Normative Cognitive Decline in Old Age</title><author>Wilson, Robert S. ; Wang, Tianhao ; Yu, Lei ; Bennett, David A. ; Boyle, Patricia A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5101-f1f264547f56441e506f0dcb45f8bc999ce17794c43e2573c095d5c16b54cc43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Aging - psychology</topic><topic>Alzheimer's disease</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Autopsy</topic><topic>Biomarkers</topic><topic>Cerebrovascular Disorders - pathology</topic><topic>Cerebrovascular Disorders - psychology</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - psychology</topic><topic>Death</topic><topic>Dementia disorders</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Educational Status</topic><topic>Female</topic><topic>Frailty - psychology</topic><topic>Heterogeneity</topic><topic>Hippocampus</topic><topic>Humans</topic><topic>Lewy bodies</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Markers</topic><topic>Memory</topic><topic>Memory, Episodic</topic><topic>Mortality</topic><topic>Neurodegenerative diseases</topic><topic>Neurodegenerative Diseases - pathology</topic><topic>Neurodegenerative Diseases - psychology</topic><topic>Neurologic Examination</topic><topic>Neuropathology</topic><topic>Neuropsychological Tests</topic><topic>Older people</topic><topic>Pathology</topic><topic>Reaction Time</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, Robert S.</creatorcontrib><creatorcontrib>Wang, Tianhao</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Bennett, David A.</creatorcontrib><creatorcontrib>Boyle, Patricia A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, Robert S.</au><au>Wang, Tianhao</au><au>Yu, Lei</au><au>Bennett, David A.</au><au>Boyle, Patricia A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Normative Cognitive Decline in Old Age</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>87</volume><issue>6</issue><spage>816</spage><epage>829</epage><pages>816-829</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><abstract>Objective
To characterize trajectories of normative cognitive aging.
Methods
Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 postmortem markers of common neurodegenerative and cerebrovascular conditions. To accommodate the heterogeneity in cognitive trajectories, we used functional mixed effects models, which allow individuals to have different patterns of cognitive decline under a unified model structure.
Results
In a functional mixed effects model, postmortem markers (Alzheimer disease pathology, Lewy bodies, transactive response DNA‐binding protein 43 pathology, hippocampal sclerosis, atherosclerosis, gross infarcts) were associated with global cognitive decline. Residual global cognitive decline after adjustment for neuropathologic burden was weakly related to age at death; it occurred in only about one‐third of participants, mostly proximate to death. Results were comparable after eliminating the initial cognitive assessments to minimize retest learning or controlling for frailty proximate to death. Analyses were also conducted with composite measures of episodic memory and perceptual speed. Residual decline not attributable to neuropathologic burden was confined to a subset for each outcome and was most evident proximate to death. Age at death was unrelated to residual decline in episodic memory but was related to residual decline in perceptual speed.
Interpretation
Late life cognitive loss mainly reflects non‐normative pathologic and mortality‐related processes rather than normative age‐related processes. ANN NEUROL 2020;87:816–829</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>32144793</pmid><doi>10.1002/ana.25711</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-9592-0333</orcidid><orcidid>https://orcid.org/0000-0002-0237-8758</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-5134 |
ispartof | Annals of neurology, 2020-06, Vol.87 (6), p.816-829 |
issn | 0364-5134 1531-8249 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10035056 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Age Aged Aged, 80 and over Aging Aging - psychology Alzheimer's disease Arteriosclerosis Atherosclerosis Autopsy Biomarkers Cerebrovascular Disorders - pathology Cerebrovascular Disorders - psychology Cognitive ability Cognitive Dysfunction - psychology Death Dementia disorders Deoxyribonucleic acid DNA Educational Status Female Frailty - psychology Heterogeneity Hippocampus Humans Lewy bodies Longitudinal Studies Male Markers Memory Memory, Episodic Mortality Neurodegenerative diseases Neurodegenerative Diseases - pathology Neurodegenerative Diseases - psychology Neurologic Examination Neuropathology Neuropsychological Tests Older people Pathology Reaction Time Reference Values |
title | Normative Cognitive Decline in Old Age |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A28%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Normative%20Cognitive%20Decline%20in%20Old%20Age&rft.jtitle=Annals%20of%20neurology&rft.au=Wilson,%20Robert%20S.&rft.date=2020-06&rft.volume=87&rft.issue=6&rft.spage=816&rft.epage=829&rft.pages=816-829&rft.issn=0364-5134&rft.eissn=1531-8249&rft_id=info:doi/10.1002/ana.25711&rft_dat=%3Cproquest_pubme%3E2405201633%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2405201633&rft_id=info:pmid/32144793&rfr_iscdi=true |